Role of brain serotonin dysfunction in the pathophysiology of congestive heart failure

Journal of Molecular and Cellular Cardiology

Volumn 53, Issue 6, 2012, Pages 760-767

  Li, Lei ^a   Morimoto, Sachio ^a   Take, Sachiko ^a   Zhan, Dong Yun ^b   Du, Cheng Kun ^b   Wang, Yuan Yuan ^a   Fan, Xue Li ^a   Yoshihara, Tatsuya ^a   Takahashi Yanaga, Fumi ^a   Katafuchi, Toshihiko ^a   Sasaguri, Toshiyuki ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

Author keywords

Brain; Cardiac vagal outflow; Congestive heart failure; Serotonin; Tryptophan hydroxylase 2

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; BUSPIRONE; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; MITOGEN ACTIVATED PROTEIN KINASE P38; PAROXETINE; PROTEIN KINASE B; SARCOPLASMIC RETICULUM CALCIUM TRANSPORTING ADENOSINE TRIPHOSPHATASE; SEROTONIN; TRYPTOPHAN HYDROXYLASE 2;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANXIETY; ARTICLE; BRAIN DYSFUNCTION; CARDIOMEGALY; CONGESTIVE CARDIOMYOPATHY; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; DEPRESSION; ENZYME PHOSPHORYLATION; GENE; MOUSE; NONHUMAN; PATHOGENESIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; SEROTONIN DYSFUNCTION; SINGLE NUCLEOTIDE POLYMORPHISM; STRAIN DIFFERENCE; SYSTOLIC DYSFUNCTION; THP2 GENE; TREATMENT OUTCOME;

ANIMALS; BRAIN; DISEASE MODELS, ANIMAL; HEART; HEART FAILURE; HUMANS; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, TRANSGENIC; MYOCARDIUM; PHENOTYPE; SEROTONIN; SEROTONIN 5-HT1 RECEPTOR AGONISTS;

MUS;

EID: 84869082344     PISSN: 00222828     EISSN: 10958584     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2012.08.006     Document Type: Article

References (37)

1. Dec G.W., Fuster V. Idiopathic dilated cardiomyopathy. N Engl J Med Dec 8 1994, 331(23):1564-1575.
2. Fuster V., Gersh B.J., Giuliani E.R., Tajik A.J., Brandenburg R.O., Frye R.L. The natural history of idiopathic dilated cardiomyopathy. Am J Cardiol Mar 1981, 47(3):525-531.
3. Fatkin D., Graham R.M. Molecular mechanisms of inherited cardiomyopathies. Physiol Rev Oct 2002, 82(4):945-980.
4. Morimoto S. Sarcomeric proteins and inherited cardiomyopathies. Cardiovasc Res Mar 1 2008, 77(4):659-666.
5. Otten E., Lekanne Dit Deprez R.H., Weiss M.M., van Slegtenhorst M., Joosten M., van der Smagt J.J., et al. Recurrent and founder mutations in the Netherlands: mutation p.K217del in troponin T2, causing dilated cardiomyopathy. Neth Heart J Oct 2010, 18(10):478-485.
6. Kamisago M., Sharma S.D., DePalma S.R., Solomon S., Sharma P., McDonough B., et al. Mutations in sarcomere protein genes as a cause of dilated cardiomyopathy. N Engl J Med Dec 7 2000, 343(23):1688-1696.
7. Vaccarino V., Kasl S.V., Abramson J., Krumholz H.M. Depressive symptoms and risk of functional decline and death in patients with heart failure. J Am Coll Cardiol Jul 2001, 38(1):199-205.
8. Jiang W., Alexander J., Christopher E., Kuchibhatla M., Gaulden L.H., Cuffe M.S., et al. Relationship of depression to increased risk of mortality and rehospitalization in patients with congestive heart failure. Arch Intern Med Aug 13-27 2001, 161(15):1849-1856.
9. Faris R., Purcell H., Henein M.Y., Coats A.J. Clinical depression is common and significantly associated with reduced survival in patients with non-ischaemic heart failure. Eur J Heart Fail Aug 2002, 4(4):541-551.
10. Rutledge T., Reis V.A., Linke S.E., Greenberg B.H., Mills P.J. Depression in heart failure a meta-analytic review of prevalence, intervention effects, and associations with clinical outcomes. J Am Coll Cardiol Oct 17 2006, 48(8):1527-1537.
11. Cowen P.J. Serotonin and depression: pathophysiological mechanism or marketing myth?. Trends Pharmacol Sci Sep 2008, 29(9):433-436.
12. Zhang X., Gainetdinov R.R., Beaulieu J.M., Sotnikova T.D., Burch L.H., Williams R.B., et al. Loss-of-function mutation in tryptophan hydroxylase-2 identified in unipolar major depression. Neuron Jan 6 2005, 45(1):11-16.
13. Zhang X., Beaulieu J.M., Sotnikova T.D., Gainetdinov R.R., Caron M.G. Tryptophan hydroxylase-2 controls brain serotonin synthesis. Science Jul 9 2004, 305(5681):217.
14. Cryan J.F., Holmes A. The ascent of mouse: advances in modelling human depression and anxiety. Nat Rev Drug Discov Sep 2005, 4(9):775-790.
15. Anisman H., Hayley S., Kelly O., Borowski T., Merali Z. Psychogenic, neurogenic, and systemic stressor effects on plasma corticosterone and behavior: mouse strain-dependent outcomes. Behav Neurosci Apr 2001, 115(2):443-454.
16. Shanks N., Anisman H. Strain-specific effects of antidepressants on escape deficits induced by inescapable shock. Psychopharmacology (Berl) 1989, 99(1):122-128.
17. Griebel G., Belzung C., Perrault G., Sanger D.J. Differences in anxiety-related behaviours and in sensitivity to diazepam in inbred and outbred strains of mice. Psychopharmacology (Berl) Feb 2000, 148(2):164-170.
18. Lucki I., Dalvi A., Mayorga A.J. Sensitivity to the effects of pharmacologically selective antidepressants in different strains of mice. Psychopharmacology (Berl) May 2001, 155(3):315-322.
19. Du C.K., Morimoto S., Nishii K., Minakami R., Ohta M., Tadano N., et al. Knock-in mouse model of dilated cardiomyopathy caused by troponin mutation. Circ Res Jul 20 2007, 101(2):185-194.
20. Nishii K., Morimoto S., Minakami R., Miyano Y., Hashizume K., Ohta M., et al. Targeted disruption of the cardiac troponin T gene causes sarcomere disassembly and defects in heartbeat within the early mouse embryo. Dev Biol Oct 1 2008, 322(1):65-73.
21. Millane T., Jackson G., Gibbs C.R., Lip G.Y. ABC of heart failure. Acute and chronic management strategies. BMJ Feb 26 2000, 320(7234):559-562.
22. Nakaura H., Morimoto S., Yanaga F., Nakata M., Nishi H., Imaizumi T., et al. Functional changes in troponin T by a splice donor site mutation that causes hypertrophic cardiomyopathy. Am J Physiol Aug 1999, 277(2 Pt 1):C225-C232.
23. Wang Y.-M., Gainetdinov R.R., Fumagalli F., Xu F., Jones S.R., Bock C.B., et al. Knockout of the vesicular monoamine transporter 2 gene results in neonatal death and supersensitivity to cocaine and amphetamine. Neuron 1997, 19(6):1285-1296. 1997/12.
24. Potter E.K. Inspiratory inhibition of vagal responses to baroreceptor and chemoreceptor stimuli in the dog. J Physiol Jul 1981, 316:177-190.
25. Rozanski A., Blumenthal J.A., Kaplan J. Impact of psychological factors on the pathogenesis of cardiovascular disease and implications for therapy. Circulation Apr 27 1999, 99(16):2192-2217.
26. Kenessey A., Ojamaa K. Thyroid hormone stimulates protein synthesis in the cardiomyocyte by activating the Akt-mTOR and p70S6K pathways. J Biol Chem Jul 28 2006, 281(30):20666-20672.
27. Kinugawa K., Jeong M.Y., Bristow M.R., Long C.S. Thyroid hormone induces cardiac myocyte hypertrophy in a thyroid hormone receptor alpha1-specific manner that requires TAK1 and p38 mitogen-activated protein kinase. Mol Endocrinol Jun 2005, 19(6):1618-1628.
28. 2+-handling in failing human myocardium. J Mol Cell Cardiol Jul 2001, 33(7):1345-1353.
29. DiPaola N.R., Sweet W.E., Stull L.B., Francis G.S., Schomisch Moravec C. Beta-adrenergic receptors and calcium cycling proteins in non-failing, hypertrophied and failing human hearts: transition from hypertrophy to failure. J Mol Cell Cardiol Jun 2001, 33((6):1283-1295.
30. Bibevski S., Dunlap M.E. Evidence for impaired vagus nerve activity in heart failure. Heart Fail Rev Mar 2011, 16(2):129-135.
31. Jordan D. Vagal control of the heart: central serotonergic (5-HT) mechanisms. Exp Physiol Mar 2005, 90(2):175-181.
32. Walther D.J., Peter J.U., Bashammakh S., Hortnagl H., Voits M., Fink H., et al. Synthesis of serotonin by a second tryptophan hydroxylase isoform. Science Jan 3 2003, 299(5603):76.
33. Alenina N., Kikic D., Todiras M., Mosienko V., Qadri F., Plehm R., et al. Growth retardation and altered autonomic control in mice lacking brain serotonin. Proc Natl Acad Sci U S A Jun 23 2009, 106(25):10332-10337.
34. Siesser W.B., Zhang X., Jacobsen J.P., Sotnikova T.D., Gainetdinov R.R., Caron M.G. Tryptophan hydroxylase 2 genotype determines brain serotonin synthesis but not tissue content in C57Bl/6 and BALB/c congenic mice. Neurosci Lett Aug 30 2010, 481(1):6-11.
35. Wang Y., Ramage A.G. The role of central 5-HT(1A) receptors in the control of B-fibre cardiac and bronchoconstrictor vagal preganglionic neurones in anaesthetized cats. J Physiol Nov 1 2001, 536(Pt 3):753-767.
36. O'Connor C.M., Jiang W., Kuchibhatla M., Silva S.G., Cuffe M.S., Callwood D.D., et al. Safety and efficacy of sertraline for depression in patients with heart failure: results of the SADHART-CHF (Sertraline Against Depression and Heart Disease in Chronic Heart Failure) trial. J Am Coll Cardiol Aug 24 2010, 56(9):692-699.
37. Walsh B.T., Seidman S.N., Sysko R., Gould M. Placebo response in studies of major depression: variable, substantial, and growing. JAMA Apr 10 2002, 287(14):1840-1847.